These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7617797)

  • 1. Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.
    Hiltunen AJ; Lafolie P; Martel J; Ottosson EC; Boreus LO; Beck O; Borg S; Hjemdahl P
    Psychopharmacology (Berl); 1995 Mar; 118(2):122-6. PubMed ID: 7617797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
    Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
    Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craving despite extremely high methadone dosage.
    de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
    Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three oral formulations of methadone. A clinical and pharmacodynamic comparison.
    Gourevitch MN; Hartel D; Tenore P; Freeman K; Marion I; Hecht J; Lowinson J
    J Subst Abuse Treat; 1999 Oct; 17(3):237-41. PubMed ID: 10531630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
    Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
    Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.
    Jittiwutikarn J; Ali R; White JM; Bochner F; Somogyi AA; Foster DJ
    Br J Clin Pharmacol; 2004 Nov; 58(5):536-41. PubMed ID: 15521902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of plasma levels to optimize methadone maintenance treatment.
    Loimer N; Schmid R
    Drug Alcohol Depend; 1992 Aug; 30(3):241-6. PubMed ID: 1396105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
    Mitchell TB; Dyer KR; Newcombe D; Salter A; Somogyi AA; Bochner F; White JM
    Br J Clin Pharmacol; 2004 Dec; 58(6):609-17. PubMed ID: 15563359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
    Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How should opiate withdrawal be measured?
    Turkington D; Drummond DC
    Drug Alcohol Depend; 1989 Oct; 24(2):151-3. PubMed ID: 2676443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway.
    Chalabianloo F; Fadnes LT; Høiseth G; Ohldieck C; Vold JH; Aas C; Løberg EM; Johansson KA; Bramness JG
    Subst Abuse Treat Prev Policy; 2021 May; 16(1):39. PubMed ID: 33941217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatment.
    Shiran MR; Lennard MS; Iqbal MZ; Lagundoye O; Seivewright N; Tucker GT; Rostami-Hodjegan A
    J Clin Psychopharmacol; 2012 Oct; 32(5):666-71. PubMed ID: 22926601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
    Baño Rodrigo MD; Agujetas Rodríguez M; López García ML; Guillén Llera JL
    Rev Clin Esp; 2000 Jan; 200(1):12-4. PubMed ID: 10721283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 'very low-dose phenobarbital' to investigate compliance in patients on reducing doses of methadone (detoxification).
    Wolff K; Hay AA; Raistrick D; Feely M
    J Subst Abuse Treat; 1993; 10(5):453-8. PubMed ID: 8246320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment.
    Elkader AK; Brands B; Callaghan R; Sproule BA
    Drug Alcohol Depend; 2009 Dec; 105(3):209-14. PubMed ID: 19713051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
    Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.